Eris Biotech

American Fork, United States

Eris Biotech is a biotech company that developing hypoxia-activated prodrugs (HAPs) for the treatment of solid tumors.

$500K raised

Feb 2024

Pre-Seed

Top Investors

Y Combinator

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Eris Biotech raised?

Eris Biotech has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in February 2024.

Who are Eris Biotech's investors?

Eris Biotech's investors include Y Combinator.

Where is Eris Biotech headquartered?

Eris Biotech is headquartered in American Fork, United States.

What does Eris Biotech do?

Eris Biotech is a biotech company that developing hypoxia-activated prodrugs (HAPs) for the treatment of solid tumors.

What stage is Eris Biotech at?

Eris Biotech is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 8, 2024.

MLA

"Eris Biotech — Funding & Investors." VCBacked, February 8, 2024, https://www.vcbacked.co/company/eris-biotech. Accessed June 30, 2026.

APA

VCBacked. (2024). Eris Biotech — Funding & Investors. Retrieved June 30, 2026, from https://www.vcbacked.co/company/eris-biotech

Wikipedia (cite web)

{{cite web |title=Eris Biotech — Funding & Investors |url=https://www.vcbacked.co/company/eris-biotech |website=VCBacked |access-date=June 30, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 8, 2024.